Results 61 to 70 of about 7,286 (173)
Airway Involvement in Conradi–Hünermann–Happle Syndrome: A Novel Clinical Manifestation
We report the first documented case of airway involvement in Conradi–Hünermann–Happle syndrome (CDPX2), an X‐linked dominant form of chondrodysplasia punctata caused by pathogenic variants in EBP. A 2‐month‐old female with genetically confirmed CDPX2 developed severe subglottic stenosis and persistent respiratory distress requiring CPAP; cross ...
Enrique G. Villarreal +3 more
wiley +1 more source
Prevalence of celiac disease in Egyptian pediatric patients with idiopathic short stature [PDF]
Open accessCorresponding author Nahla Ahmed Mohammed * Email: anahla69@yahoo.comMobile: +201001262166Received: 1 April 2026Accepted: 30 April 2026Published: 21 May 2026 Citation: Nahla A Mohammed*, Mariam Z M Daowd, Hanan F Mohammed, and Manal O Mohammed.
Nahla Mohammed +3 more
doaj +1 more source
Background: Short stature is a common problem encountered by endocrinologists. Short stature may be due to normal variations of growth or pathologic process.
Vahid Sheikhi +2 more
doaj
Comparative efficacy of mono- and combined therapy for idiopathic short stature with delayed puberty
Background. Growth hormone therapy for idiopathic short stature (ISS) is a subject of debate, because of the heterogeneous endocrine profile in these children.
G.N. Rakhimova, K.N. Gilyazetdinov
doaj +1 more source
ABSTRACT KBG syndrome is a rare autosomal dominant neurodevelopmental disorder caused by ANKRD11 haploinsufficiency and is characterized by short stature, distinctive facial features, intellectual disability or developmental delay, congenital anomalies and skeletal anomalies.
Marit van der Leij +5 more
wiley +1 more source
Management of children with idiopathic short stature [PDF]
The Food and Drug Administration (FDA) approved the use of biosynthetic GH for the treatment of children with idiopathic short stature (ISS) in the US in 2003. Primarily, the decision was based on two studies: a randomized placebo-controlled study and a dose–response study, both demonstrating an increase in adult height over the predicted height at ...
openaire +1 more source
Managing idiopathic short stature: role of somatropin (rDNA origin) for injection
J Paul Frindik1, Stephen F Kemp11University of Arkansas for Medical Sciences and Arkansas Children’s Hospital, AR, USAAbstract: Idiopathic short stature (ISS) is a term that describes short stature in children who do not have growth hormone (GH)
J Paul Frindik, Stephen F Kemp
doaj
The Etiological Spectrum OF Short Stature among Children Attending Endocrine Clinic at Tertiary Care Hospital [PDF]
Background: One of the most frequent reasons for referral to pediatric endocrinology units is short stature. Children’s short height has a complicated etiology that includes genetics, race, gender, nutrition, and several endocrine hormones.
Hira Urooj Iqbal +3 more
doaj +1 more source
Monogenic causes of familial short stature
Genetic factors play a crucial role in determining human height. Short stature commonly affects multiple family members and therefore, familial short stature (FSS) represents a significant proportion of growth disorders. Traditionally, FSS was considered
Lukas Plachy +6 more
doaj +1 more source
Ghrelin Plasma Levels in Patients with Idiopathic Short Stature
<i>Background:</i> Novel molecular insights have suggested that ghrelin may be involved in the pathogenesis of some forms of short stature. Recently, growth hormone secretagogue receptor (GHSR) mutations that segregate with short stature have been reported.
Iñíguez Vila, Germán +4 more
openaire +5 more sources

